🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Lung Transplant Rejection

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. NCT06018766Phase 21 site📍 San Francisco Steven Hays, MD · Tests: LAM-001, Placebo Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation NCT02812290n/a11 sites📍 Phoenix📍 Baltimore📍 St Louis University of Alberta · Tests: Lung transplant biopsy bites. GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation NCT07516379n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes NCT06399302n/a19 sites📍 Los Angeles📍 San Francisco📍 Stanford Duke University Cryoprobe Biopsy and Chronic Rejection in Lung Transplant Recipients NCT06824402NA1 site📍 Rochester Mayo Clinic · Tests: Forceps Biopsy, Cryoprobe Biopsy Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients NCT06476132Phase 212 sites📍 Los Angeles📍 Palo Alto📍 Baltimore National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Belumosudil, Placebo for Belumosudil Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients NCT01531257n/a1 site📍 Chicago Northwestern University Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Lung Transplant Recipients NCT04582279NA1 site📍 Jacksonville Mayo Clinic · Tests: Lung ultrasound A Prospective Randomized Trial of ECP in Subclinical AMR NCT06112951NA7 sites📍 Vienna📍 Leuven📍 Zagreb Medical University of Vienna · Tests: Extracorporeal Photopheresis Noninvasive Early Detection of Lung Allograft Dysfunction After Lung Transplantation With Multiple Breath Washout Test NCT05586906NA1 site📍 Zurich University of Zurich · Tests: Multiple Breath Washout (MBW) tests Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD NCT07434869n/a3 sites📍 Boston📍 Boston📍 Columbus Brian Keller Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation NCT04837339NA1 site📍 Suresnes Hopital Foch · Tests: Collection of biological samples A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation NCT06990711Phase 12 sites📍 St Louis📍 Saint Lake City Washington University School of Medicine · Tests: Siltuximab, Placebo Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO NCT06679257n/a1 site📍 Gothenburg Jesper Magnusson · Tests: cell-free dNA Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU NCT06538376NA1 site📍 Boston Brigham and Women's Hospital · Tests: Portable Dynamic Digital Radiography (DDR) Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection NCT07046910Phase 21 site📍 Charlottesville University of Virginia · Tests: Sub study (Active): Two Lung MRI study with two navigational Bronchoscopy, Hyperpolarized Xenon129 A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction NCT06082037Phase 382 sites📍 Birmingham📍 Phoenix📍 Los Angeles Sanofi · Tests: Belumosudil, Azithromycin, Placebo Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies NCT06948097Phase 14 sites📍 Stanford📍 Baltimore📍 Salt Lake City National Heart, Lung, and Blood Institute (NHLBI) · Tests: fostamatinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy